Location: Greenwich, CT
CIK: 0001856083 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $6.87B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GH | GUARDANT HEALTH INC | 3,393,312 | $509M | 7.4% | — | — | COM | 40131M109 |
| IMVT | IMMUNOVANT INC | 9,341,151 | $360M | 5.2% | — | — | COM | 45258J102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 4,740,072 | $254M | 3.7% | — | — | SPONSORED ADS | 86366E106 |
| PCVX | VAXCYTE INC | 4,300,000 | $250M | 3.6% | — | — | COM | 92243G108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 825,000 | $248M | 3.6% | — | — | COM | 02043Q107 |
| MANE | VERADERMICS INC | 2,000,000 | $246M | 3.6% | — | — | COMMON STOCK | 922967104 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,666,768 | $231M | 3.4% | — | — | COM | 87650L103 |
| NUVL | NUVALENT INC | 1,783,322 | $220M | 3.2% | — | — | COM | 670703107 |
| ALKS | ALKERMES PLC | 4,000,000 | $210M | 3.1% | — | — | SHS | G01767105 |
| OCUL | OCULAR THERAPEUTIX INC | 19,686,282 | $193M | 2.8% | — | — | COM | 67576A100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,307,481 | $189M | 2.8% | — | — | COM | 09061G101 |
| NRIX | NURIX THERAPEUTICS INC | 7,736,455 | $188M | 2.7% | — | — | COM | 67080M103 |
| ORKA | ORUKA THERAPEUTICS INC | 1,926,000 | $183M | 2.7% | — | — | COM | 687604108 |
| ALMS | ALUMIS INC | 6,348,558 | $179M | 2.6% | — | — | COM | 022307102 |
| IONS | IONIS PHARMACEUTICALS INC | 2,200,000 | $174M | 2.5% | — | — | COM | 462222100 |
| CMPS | COMPASS PATHWAYS PLC | 12,161,496 | $172M | 2.5% | — | — | SPONSORED ADS | 20451W101 |
| VERA | VERA THERAPEUTICS INC | 4,000,000 | $172M | 2.5% | — | — | CL A | 92337R101 |
| AXSM | AXSOME THERAPEUTICS INC. | 700,000 | $171M | 2.5% | — | — | COM | 05464T104 |
| GMAB | GENMAB A/S | 5,650,000 | $155M | 2.3% | — | — | SPONSORED ADS | 372303206 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 6,999,025 | $136M | 2.0% | — | — | CLASS A ORD | 61559X104 |
| COAG | HEMAB THERAPEUTICS HLDGS INC | 3,602,093 | $132M | 1.9% | — | — | COM SHS | 423494103 |
| TNGX | TANGO THERAPEUTICS INC | 4,200,000 | $131M | 1.9% | — | — | COM | 87583X109 |
| DFTX | DEFINIUM THERAPEUTICS INC | 2,750,000 | $129M | 1.9% | — | — | COM SHS | 24477V105 |
| GRAL | GRAIL INC | 1,834,944 | $125M | 1.8% | — | — | COM | 384747101 |
| BCAX | BICARA THERAPEUTICS INC | 4,100,000 | $122M | 1.8% | — | — | COM | 055477103 |
| MAZE | MAZE THERAPEUTICS INC | 3,732,569 | $111M | 1.6% | — | — | COM | 578784100 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,939,151 | $109M | 1.6% | — | — | COM NEW | 15117B202 |
| LBRX | LB PHARMACEUTICALS INC | 3,352,804 | $109M | 1.6% | — | — | COM SHS | 50180M108 |
| MBX | MBX BIOSCIENCES INC | 1,732,569 | $95.64M | 1.4% | — | — | COM | 55287L101 |
| GHRS | GH RESEARCH PLC | 3,333,334 | $89.6M | 1.3% | — | — | ORDINARY SHARES | G3855L106 |
| GMAB | GENMAB A/S | 3,000,000 | $82.41M | 1.2% | — | — | Call | 372303206 |
| COGT | COGENT BIOSCIENCES INC | 2,000,000 | $77.4M | 1.1% | — | — | COM | 19240Q201 |
| ATAI | ATAIBECKLEY INC | 14,417,442 | $75.98M | 1.1% | — | — | COM SHS | 04650F101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 123,616 | $66.98M | 1.0% | — | — | COM | 91307C102 |
| AVTX | AVALO THERAPEUTICS INC | 3,610,000 | $66.71M | 1.0% | — | — | COM NEW | 05338F306 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,592,740 | $66M | 1.0% | — | — | COM | 92790C104 |
| CYTK | CYTOKINETICS INC | 700,000 | $59.63M | 0.9% | — | — | COM NEW | 23282W605 |
| ALT | ALTIMMUNE INC | 19,250,000 | $58.52M | 0.9% | — | — | COM NEW | 02155H200 |
| PSNL | PERSONALIS INC | 4,000,000 | $53.6M | 0.8% | — | — | COM | 71535D106 |
| ACRS | ACLARIS THERAPEUTICS INC | 9,345,000 | $49.44M | 0.7% | — | — | COM | 00461U105 |
| CRMD | CORMEDIX INC | 6,274,076 | $49.25M | 0.7% | — | — | COM | 21900C308 |
| WGS | GENEDX HOLDINGS CORP | 700,000 | $48.05M | 0.7% | — | — | COM CL A | 81663L200 |
| HROW | HARROW INC | 969,000 | $41.15M | 0.6% | — | — | COM | 415858109 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,491,939 | $37.23M | 0.5% | — | — | COM | 221015100 |
| SLDB | SOLID BIOSCIENCES INC | 3,565,062 | $35.61M | 0.5% | — | — | COM NEW | 83422E204 |
| BEAM | BEAM THERAPEUTICS INC | 1,000,000 | $34.32M | 0.5% | — | — | COM | 07373V105 |
| DYN | DYNE THERAPEUTICS INC | 1,500,000 | $33.31M | 0.5% | — | — | COM | 26818M108 |
| IMMX | IMMIX BIOPHARMA INC | 2,775,000 | $28.61M | 0.4% | — | — | COM | 45258H106 |
| XFOR | X4 PHARMACEUTICALS INC | 5,878,757 | $27.45M | 0.4% | — | — | COM NEW | 98420X202 |
| STTK | SHATTUCK LABS INC | 3,706,734 | $25.72M | 0.4% | — | — | COM | 82024L103 |
| MNKD | MANNKIND CORP | 6,000,000 | $25.56M | 0.4% | — | — | COM NEW | 56400P706 |
| IPSC | CENTURY THERAPEUTICS INC | 9,462,645 | $23.18M | 0.3% | — | — | COM | 15673T100 |
| GENB | GENERATE BIOMEDICINES INC | 1,333,815 | $22.5M | 0.3% | — | — | COM SHS | 370920100 |
| VSTM | VERASTEM INC | 5,740,850 | $21.93M | 0.3% | — | — | COM NEW | 92337C203 |
| KURA | KURA ONCOLOGY INC | 1,978,565 | $21.7M | 0.3% | — | — | COM | 50127T109 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,444,167 | $21.06M | 0.3% | — | — | COM | 29251M106 |
| NKTR | NEKTAR THERAPEUTICS | 300,000 | $20.94M | 0.3% | — | — | COM NEW | 640268306 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,500,000 | $18.77M | 0.3% | — | — | COM | 68062P106 |
| KLRA | KAILERA THERAPEUTICS INC | 700,000 | $15.42M | 0.2% | — | — | COMMON STOCK | 482931102 |
| KARD | KARDIGAN INC | 600,000 | $14.31M | 0.2% | — | — | COM | 485925101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 225,000 | $11.42M | 0.2% | — | — | COM | 29337E102 |
| PMN | PROMIS NEUROSCIENCES INC | 835,655 | $11M | 0.2% | — | — | COM SHS | 74346M505 |
| IMCR | IMMUNOCORE HLDGS PLC | 311,218 | $9.881M | 0.1% | — | — | ADS | 45258D105 |
| XNCR | XENCOR INC | 593,551 | $9.556M | 0.1% | — | — | COM | 98401F105 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $4.11M | 0.1% | — | — | COM | 21077P108 |
| IVA | INVENTIVA SA | 800,000 | $3.024M | 0.0% | — | — | ADS | 46124U107 |
| ALGS | ALIGOS THERAPEUTICS INC | 444,110 | $2.563M | 0.0% | — | — | COM NEW | 01626L204 |